Hunan Sinoland Bio-pharmacy CO., Ltd. is a high-tech enterprise specializing in the research, development, production and sales of livestock and poultry bio-products, and also a veterinary bio-products manufacturer in Hunan Province.
The "Animal Vaccine Workshop Reconstruction and Expansion Project" invested by Sinoland Bio-pharmacy, with an investment of 60 million yuan, covers an area of 8,400 square meters. After the project is completed, four modern production lines will be put into...
I. Boiler demand:
1. The user needs several sets of steam boilers according to the heat demand
2. The boilers are used for supplying steam and heat energy for the production base.
3. The user puts high requirements on the environmental protection performance and emissions.
II. User Profile:
Biocytogen Jiangsu Co., Ltd. was founded in 2014, it is a branch of the Biocytogen. The company is mainly engaged in scientific research and technical service industry. H...
The pharmaceutical industry has a huge demand for steam. Tablet pharmaceutical processes mainly involve disinfection, drying, pressing, etc. These processes require a large amount of steam to sterilize raw materials, instruments and equipment at high temperature, at the same time, drying, pressing and other processes also need the support of steam.
The preparation process of common drug mainly involves disinfection, rough washing, fine washing, drying, cooling, etc. A large amount of industrial steam and pure steam are used to sterilize raw materials, instruments and equipment at high temperature, and heat is supplied during drying, cooling, tableting, granulation and other links.
In the pharmaceutical industry, the production and processing of many medicines require the sufficient and stable steam heat source with high quality. By virtue of abundant project experience in the pharmaceutical industry, ZOZEN Boiler reached a friendly cooperation with Zhejiang Haisen Pharmaceutical Co., Ltd. on the WNS series two-pass gas-fired steam boiler. Haisen Pharmaceutical is a high-tech enterprise engaged in the R&D, production and operation of APIs and pharmaceutical intermediates. The company's main products are APIs including sucralfate, analgin, pazufloxacin mesilate, atorvastatin calcium, paroxetine hydrochloride, escitalopram oxalate and pharmaceutical intermediates including PHBA, N-Methylparoxetine, etc.
Hubei Grand Life Science and Technology Co., Ltd., founded in 1995 and formerly known as Huanggang Fuchi Pharmaceutical Co., Ltd., is a wholly-owned subsidiary of Grandpharma (China) Co., Ltd.. Hubei Grand adopts the taurine production process using ethylene oxide as the initial raw material, which requires a sufficient and stable heat source supply provided by the boiler equipment with high requirements. In order to better meet the heat source demand of the taurine production line, Hubei Grand finally chose ZOZEN's YLW series coal-fired horizontal thermal oil heater.
Based on the abundant experience accumulated from the cooperation with numerous pharmaceutical enterprises, ZOZEN Boiler customized two sets of WNS series gas-fired steam boiler featured with safe operation, energy saving and few environmental pollution that could meet the actual demands of production lines, which won the satisfaction and trust of Haida Shehuage Pharmaceutical.
During the production of Alpha GPC, the process of evaporation and concentration requires high temperature steam provided by steam boilers. In order to respond to the call of clean production, Foman Biopharma selected a set of ZOZEN boiler which used natural gas as fuel. Meanwhile, ZOZEN customized the WNS series gas-fired boiler solution according the actual steam needs of Foman Biopharma. This series of boilers are wetback fire-tube boilers. With a three-pass design, the boiler adopts a large-diameter corrugated furnace. A combination of threaded flue tubes and smooth flue tubes is designed to increase the flue gas flow and optimize the heat transfer effect.
Besides, energy saving devices are equipped at the tail of the flue to fully absorb the heat energy and improve the thermal efficiency of the boiler to more than 98%, which can reduce operating costs for Foman Biopharma.
